GGrantIndex
Sort

1,049,261 grants matching t cell

Flow Cytometry

$2,613,386
Carl Bortner · National Institute Of Environmental Health Sciences · ZIC · FY2023 · ES

Organ engineering based on perfusion decellularized matrix

$2,613,250
Harald C Ott · Massachusetts General Hospital · DP2 · FY2011 · OD

Characterizing lymphatic micrometastases: prognostic and therapeutic implications

$2,613,250
Timothy P Padera · Massachusetts General Hospital · DP2 · FY2011 · OD

Vascular Cell Signaling and Atherogenesis

$2,612,954
Weill Medical College Of Cornell Univ · P01 · FY2005 · HL

Alzheimer's Disease Research Center

$2,612,940
John Morris · Washington University · P50 · FY2018 · AG

Translational Research in Breast Cancer

$2,612,827
C Kent Osborne · Baylor College Of Medicine · P50 · FY2007 · CA

Targeting Vessels in Tumors

$2,612,712
Jan E Schnitzer · Sidney Kimmel Cancer Center · P01 · FY2006 · CA

GENES OF PANCREAS FUNCTION AND DEVELOPMENT

$2,612,558
Vanderbilt University · U19 · FY2001 · DK

GENES OF PANCREAS FUNCTION AND DEVELOPMENT

$2,612,532
Vanderbilt University · U19 · FY2004 · DK

Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy

$2,612,197
Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2016 · CA

Alaska INBRE-2: Environmental Agents and Disease

$2,611,819
Jocelyn E Krebs · University Of Alaska Fairbanks · P20 · FY2011 · RR

Functional consequences of stem and progenitor cell heterogeneity

$2,611,725
David T Scadden · Massachusetts General Hospital · P01 · FY2023 · HL

Systems Biology of In Vivo Human Blood Cell Populations

$2,611,250
John Matthew Higgins · Massachusetts General Hospital · DP2 · FY2012 · DK

THERAPEUTIC STRATEGIES FOR ALZHEIMER'S DISEASE BASED ON TREM2 BIOLOGY

$2,611,246
Marco Colonna · Washington University · RF1 · FY2019 · AG

Regulation of hepatic and systemic immune responses

$2,610,971
Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK

Metabolic determinants of Mtb virulence, vulnerability and variation

$2,610,899
David Branch Moody · Brigham And Women'S Hospital · U19 · FY2024 · AI

Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes

$2,610,804
Andrew Scott Weyrich · University Of Utah · U54 · FY2014 · HL

Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV

$2,610,459
Manolis Kellis · Broad Institute, Inc. · U01 · FY2024 · DA

Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV

$2,610,459
Manolis Kellis · Broad Institute, Inc. · U01 · FY2025 · DA

Allogeneic Immunotherapy for cancer and nonmalignant hematological disorders

$2,610,373
Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL

Structural and Molecular Basis of Transduction in Auditory Sensory Organs

$2,610,315
Bechara Kachar · National Institute On Deafness And Other Communication Disorders · ZIA · FY2022 · DC

Woods Hole Center for Oceans and Human Health

$2,610,197
Dennis J McGillicuddy · Woods Hole Oceanographic Institution · · FY2024 · GEO

Glycoengineering In Vivo

$2,610,000
Robert McCullough Anthony · Massachusetts General Hospital · DP2 · FY2014 · AR

Engineering Humoral Immunity to Functionally Cure HIV Infection

$2,610,000
Alejandro Benjamin Balazs · Massachusetts General Hospital · DP2 · FY2015 · DA

Macrophage Integrated and Targeted Yeast Therapeutics

$2,610,000
Christopher Hug · Boston Children'S Hospital · DP2 · FY2011 · OD